Overweight or Obese AdultsNCT06742112
The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals
An observational study of Overweight or Obese Adults, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
Trial summary
The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in overweight and obese individuals. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Overweight or Obese Adults
- How many people
- 24 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 11 Dec 2024to Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Overweight and obese individuals will be included in the study.
Who may be able to join
- Body mass index ≥ 25 kg/m2
- Volunteering for the study
Who cannot join
- Having uncontrolled hypertension, diabetes mellitus
- Having comorbidities that may affect physical functions
- Failure to cooperate with tests to be performed
- Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases
- Pregnancy
- Having a history of bariatric surgery
- Presence of contraindications to exercise testing
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Kirsehir Ahi Evran University
Kırşehir
Merve Firat, +90 850 441 02 44, mervefirat@ahievran.edu.tr
About this study
Official title: Validity and Reliability of the 6-minute Pegboard and Ring Test in Assessing Upper Extremity Function in Overweight and Obese Individuals
The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in overweight and obese individuals.
- Conditions
- Overweight or Obese Adults
- Medical subject headings
- Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Overweight and obese individuals | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Arm exercise capacity
It will be assessed by 6 minute pegboard and ring test.
Measured: 1st day
Exercise capacity
It will be assessed by 6 minute walk test.
Measured: 1st day
Hand grip strength
Will be measured using a hang grip dynamometer.
Measured: 1st day
Muscle endurance
30 second push-up test will be used, and total number will be recorded.
Measured: 1st day
Secondary outcomes (1)
Upper extremity functional status
Upper extremity functional status will be assessed with the Upper Extremity Functional Index. This index consists of 20 questions, and the lowest possible score is 0 and the highest score is 80. Higher scores indicate better functional status.
Measured: 1st day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2024
- Study start11 Dec 2024
- Primary completionMay 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Overweight or Obese AdultsStudies of the same condition, open and under way.
- More trials run by Kirsehir Ahi Evran UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 24 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Merve Firat, Kirsehir Ahi Evran Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06742112
- Sponsor's protocol ID
- 2024-20/173
- Status last verified
- Dec 2024
- First submitted
- 16 Dec 2024
- Last updated
- 19 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Firat M, Babacan E, Kesik HI, Guner O. The validity and reliability of the six-minute pegboard and ring test for assessing upper extremity exercise capacity in individuals with overweight and obesity: a cross-sectional study. BMC Sports Sci Med Rehabil. 2026 Mar 10;18(1):276. doi: 10.1186/s13102-026-01641-9.
PubMed 41803977
Study at a glance
From the registry record, last updated by the sponsor on 19 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Reliability of the 6-minute Pegboard and Ring Test in Assessing Upper Extremity Function in Overweight and Obese Individuals
- ClinicalTrials.gov ID
- NCT06742112
- Acronym / sponsor ID
- 2024-20/173
- Conditions
- Overweight or Obese Adults
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 24 participants (estimated)
- Lead sponsor
- Kirsehir Ahi Evran UniversitesiUniversity, hospital or other
- Study start
- 11 Dec 2024 (actual)
- Primary completion
- May 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 19 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in overweight and obese individuals.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Overweight and obese individuals | – | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Overweight and obese individuals will be included in the study.
Key inclusion criteria (2 listed)
- Body mass index ≥ 25 kg/m2
- Volunteering for the study
Key exclusion criteria (7 listed)
- Having uncontrolled hypertension, diabetes mellitus
- Having comorbidities that may affect physical functions
- Failure to cooperate with tests to be performed
- Liver disease, kidney disease, cancer, lung diseases and serious cardiomyopathies, neurological diseases
- Pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Arm exercise capacity
Time frame: 1st day
It will be assessed by 6 minute pegboard and ring test.
Exercise capacity
Time frame: 1st day
It will be assessed by 6 minute walk test.
Hand grip strength
Time frame: 1st day
Will be measured using a hang grip dynamometer.
Muscle endurance
Time frame: 1st day
30 second push-up test will be used, and total number will be recorded.
1 secondary outcome
Upper extremity functional status
Time frame: 1st day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Dec 2024.
- Derived from this study: PubMed 41803977Firat M, Babacan E, Kesik HI, Guner O. The validity and reliability of the six-minute pegboard and ring test for assessing upper extremity exercise capacity in individuals with overweight and obesity: a cross-sectional study. BMC Sports Sci Med Rehabil. 2026 Mar 10;18(1):276. doi: 10.1186/s13102-026-01641-9.
- Individual participant dataSharing planned: Undecided
Related trials for Overweight or Obese Adults
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
RecruitingPhase 1
A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
Overweight and/or Obesity, Healthy Participants
RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Overweight or Obesity
RecruitingPhase 3
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity
Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Overweight or Obese Adults, run by Kirsehir Ahi Evran Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Merve Firat (+90 850 441 02 44, mervefirat@ahievran.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Arm exercise capacity (time frame: 1st day). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06742112, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2024.